Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy RAPT Therapeutics stock
Learn how to easily invest in RAPT Therapeutics stock.
RAPT Therapeutics Inc is a biotechnology business based in the US. RAPT Therapeutics shares (RAPT) are listed on the NASDAQ and all prices are listed in US Dollars. RAPT Therapeutics employs 88 staff and has a trailing 12-month revenue of around $3.2 million.
How to buy shares in RAPT Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RAPT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
RAPT Therapeutics stock price (NASDAQ: RAPT)Use our graph to track the performance of RAPT stocks over time.
RAPT Therapeutics shares at a glance
|Latest market close||$22.70|
|52-week range||$9.86 - $40.74|
|50-day moving average||$23.96|
|200-day moving average||$22.46|
|Wall St. target price||$48.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.56|
Buy RAPT Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy RAPT Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
RAPT Therapeutics price performance over time
|1 week (2022-09-16)||-7.42%|
|1 month (2022-08-24)||-22.68%|
|3 months (2022-06-24)||18.29%|
|6 months (2022-03-22)||-2.24%|
|1 year (2021-09-24)||-33.95%|
|2 years (2020-09-24)||-19.53%|
|3 years (2019-09-20)||N/A|
|5 years (2017-09-20)||N/A|
RAPT Therapeutics financials
|Revenue TTM||$3.2 million|
|Gross profit TTM||$3.8 million|
|Return on assets TTM||-21.04%|
|Return on equity TTM||-36.33%|
|Market capitalisation||$727.2 million|
TTM: trailing 12 months
RAPT Therapeutics share dividends
We're not expecting RAPT Therapeutics to pay a dividend over the next 12 months.
RAPT Therapeutics share price volatility
Over the last 12 months, RAPT Therapeutics's shares have ranged in value from as little as $9.855 up to $40.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while RAPT Therapeutics's is 0.4413. This would suggest that RAPT Therapeutics's shares are less volatile than average (for this exchange).
RAPT Therapeutics overview
RAPT Therapeutics, Inc. , a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc.
RAPT Therapeutics in the news
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know
Here's Why Rapt Therapeutics (RAPT) Looks Ripe for Bottom Fishing
Quite a few insiders invested in RAPT Therapeutics, Inc. (NASDAQ:RAPT) last year which is positive news for shareholders
Frequently asked questionsWhat percentage of RAPT Therapeutics is owned by insiders or institutions?
Currently 2.475% of RAPT Therapeutics shares are held by insiders and 103.72% by institutions. How many people work for RAPT Therapeutics?
Latest data suggests 88 work at RAPT Therapeutics. When does the fiscal year end for RAPT Therapeutics?
RAPT Therapeutics's fiscal year ends in December. Where is RAPT Therapeutics based?
RAPT Therapeutics's address is: 561 Eccles Avenue, South San Francisco, CA, United States, 94080 What is RAPT Therapeutics's ISIN number?
RAPT Therapeutics's international securities identification number is: US75382E1091 What is RAPT Therapeutics's CUSIP number?
RAPT Therapeutics's Committee on Uniform Securities Identification Procedures number is: 75382E109
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert